Are the first-trimester levels of PAPP-A and fb-hCG predictors for obstetrical complications in diabetic pregnancy?

References

• World Health Organization. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. Geneva: World Health Organization; 2013.
   Google Scholar
• Guariguata L, Linnenkamp U, Beagley J, et al. Global estimates of the prevalence of hyperglycaemia in pregnancy. Diabetes Res Clin Pract. 2014;103(2):176–185.
   PubMed Web of Science ®Google Scholar
• Balsells M, García-Patterson A, Gich I, et al. Maternal and fetal outcome in women with type 2 versus type 1 diabetes mellitus: a systematic review and metaanalysis. J Clin Endocrinol Metab. 2009;94(11):4284–4291.
   PubMed Web of Science ®Google Scholar
• Ong CYT, Liao AW, Spencer K, et al. First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. BJOG. 2000;107(10):1265–1270.
   PubMedGoogle Scholar
• Spencer K, Cicero S, Atzei A, et al. The influence of maternal insulin-dependent diabetes on fetal nuchal translucency thickness and first-trimester maternal serum biochemical markers of aneuploidy. Prenat Diagn. 2005;25(10):927–929.
   PubMed Web of Science ®Google Scholar
• Hasegawa J, Wada S, Kasamatsu A, et al. Distribution of PAPP-A and total hCG between 11 and 13 weeks of gestation in Japanese pregnant women. J Matern Neonatal Med. 2018; 1–6.
   PubMed Web of Science ®Google Scholar
• Spencer K, Cowans NJ, Chefetz I, et al. First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia. Ultrasound Obstet Gynecol. 2007;29(2):128–134.
   PubMed Web of Science ®Google Scholar
• Pummara P, Tongsong T, Wanapirak C, et al. Association of first-trimester pregnancy-associated plasma protein A levels and idiopathic preterm delivery: A population-based screening study. Taiwan J Obstet Gynecol. 2016;55(1):72–75.
   PubMed Web of Science ®Google Scholar
• Abdel Moety GAF, Almohamady M, Sherif NA, et al. Could first-trimester assessment of placental functions predict preeclampsia and intrauterine growth restriction? A prospective cohort study. J Matern Neonatal Med. 2016;29(3):413–417.
   PubMed Web of Science ®Google Scholar
• Kuc S, Wortelboer E, Koster M, et al. Prediction of macrosomia at birth in type-1 and 2 diabetic pregnancies with biomarkers of early placentation. BJOG. 2011;118(6):748–754.
   PubMed Web of Science ®Google Scholar
• González González NL, Plasencia W, González Dávila E, et al. First and second trimester screening for large for gestational age infants. J Matern Neonatal Med. 2013;26(16):1635–1640.
   PubMed Web of Science ®Google Scholar
• Savvidou M, Syngelaki A, Muhaisen M, et al. First trimester maternal serum free β-human chorionic gonadotropin and pregnancy-associated plasma protein A in pregnancies complicated by diabetes mellitus. BJOG. 2012;119(4):410–416.
   PubMed Web of Science ®Google Scholar
• Lawrence JB, Oxvig C, Overgaard MT, et al. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci. 1999;96(6):3149–3153.
   PubMed Web of Science ®Google Scholar
• Spencer K, Cowans NJ, Spencer CE, et al. A re-evaluation of the influence of maternal insulin-dependent diabetes on fetal nuchal translucency thickness and first-trimester maternal serum biochemical markers of aneuploidy. Prenat Diagn. 2010;30(10):937–940.
   PubMed Web of Science ®Google Scholar
• Farrar D, Simmonds M, Bryant M, et al. Hyperglycaemia and risk of adverse perinatal outcomes: systematic review and meta-analysis. BMJ. 2016;354:i4694.
   PubMed Web of Science ®Google Scholar
• Madsen HN, Ekelund CK, Tørring N, et al. Impact of type 1 diabetes and glycemic control on fetal aneuploidy biochemical markers. Acta Obstet Gynecol Scand. 2012;91(1):57–61.
   PubMed Web of Science ®Google Scholar
• Pedersen J, Søorensen S, Mølsted-Pedersen L. Serum levels of human placental lactogen, pregnancy-associated plasma protein A and endometrial secretory protein PP14 in first trimester of diabetic pregnancy. Acta Obstet Gynecol Scand. 1998;77(2):155–158.
   PubMed Web of Science ®Google Scholar
• Beneventi F, Simonetta M, Lovati E, et al. First trimester pregnancy-associated plasma protein-A in pregnancies complicated by subsequent gestational diabetes. Prenat Diagn. 2011;31(6):523–528.
   PubMed Web of Science ®Google Scholar
• Lovati E, Beneventi F, Simonetta M, et al. Gestational diabetes mellitus: including serum pregnancy-associated plasma protein-A testing in the clinical management of primiparous women? A case–control study. Diabetes Res. Clin. Pract. 2013;100(3):340–347.
   PubMed Web of Science ®Google Scholar
• Spencer K, Cowans NJ. The association between gestational diabetes mellitus and first trimester aneuploidy screening markers. Ann Clin Biochem. 2013;50(6):603–610.
   PubMed Web of Science ®Google Scholar
• Farina A, Eklund E, Bernabini D, et al. A first-trimester biomarker panel for predicting the development of gestational diabetes. Reprod Sci. 2017;24(6):954–959.
   PubMed Web of Science ®Google Scholar
• Tul N, Pusenjak S, Osredkar J?k, et al. Predicting complications of pregnancy with first-trimester maternal serum free-betahCG, PAPP-A and inhibin-A. Prenat Diagn. 2003;23(12):990–996.
   PubMed Web of Science ®Google Scholar
• Cheuk QKY, Lo T, Wong S, et al. Association between pregnancy-associated plasma protein-A levels in the first trimester and gestational diabetes mellitus in Chinese women. Hong Kong Med J. 2015;22:30–38.
   PubMed Web of Science ®Google Scholar
• Husslein H, Lausegger F, Leipold H, et al. Association between pregnancy-associated plasma protein-A and gestational diabetes requiring insulin treatment at 11–14 weeks of gestation. J Matern Neonatal Med. 2012;25(11):2230–2233.
   PubMed Web of Science ®Google Scholar
• Donovan BM, Nidey NL, Jasper EA, et al. First trimester prenatal screening biomarkers and gestational diabetes mellitus: a systematic review and meta-analysis. Qu H-Q, editor. PLoS One. 2018;13(7):e0201319.
   PubMed Web of Science ®Google Scholar
• Talasaz ZH, Sadeghi R, Askari F, et al. First trimesters pregnancy-associated plasma protein-a levels value to predict gestational diabetes mellitus: a systematic review and meta-analysis of the literature. Taiwan J Obstet Gynecol. 2018;57(2):181–189.
   PubMed Web of Science ®Google Scholar
• Huttly W, Rudnicka A, Wald NJ. Second-trimester prenatal screening markers for Down syndrome in women with insulin-dependent diabetes mellitus. Prenat Diagn. 2004;24(10):804–807.
   PubMed Web of Science ®Google Scholar
• Bersinger NA, Odegard RA. Second- and third-trimester serum levels of placental proteins in preeclampsia and small-for-gestational age pregnancies. Acta Obstet Gynecol Scand. 2004;83(1):37–45.
   PubMed Web of Science ®Google Scholar
• Deveci K, Sogut E, Evliyaoglu O, et al. Pregnancy-associated plasma protein-A and C-reactive protein levels in pre-eclamptic and normotensive pregnant women at third trimester. J Obstet Gynaecol Res. 2009;35(1):94–98.
   PubMed Web of Science ®Google Scholar
• Pilalis A, Souka AP, Antsaklis P, et al. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11–14 weeks’ gestation. Ultrasound Obstet Gynecol. 2007;29(2):135–140.
   PubMed Web of Science ®Google Scholar
• Walsh JM, McAuliffe FM. Prediction and prevention of the macrosomic fetus. Eur J Obstet Gynecol Reprod Biol. 2012;162(2):125–130.
   PubMed Web of Science ®Google Scholar
• Henriksen T. The macrosomic fetus: a challenge in current obstetrics. Acta Obstet Gynecol Scand. 2008;87(2):134–145.
   PubMed Web of Science ®Google Scholar
• Mitanchez D. Foetal and neonatal complications in gestational diabetes: perinatal mortality, congenital malformations, macrosomia, shoulder dystocia, birth injuries, neonatal complications. Diabetes Metab. 2010;36(6):617–627.
   PubMed Web of Science ®Google Scholar
• Poon LC, Nicolaides KH. Early prediction of preeclampsia. Obstet Gynecol Int. 2014;2014:1–11.
   Google Scholar
• Goetzinger KR, Singla A, Gerkowicz S, et al. The efficiency of first-trimester serum analytes and maternal characteristics in predicting fetal growth disorders. Am J Obstet Gynecol. 2009;201(4):412.e1–412.e6.
   PubMed Web of Science ®Google Scholar
• Allen R, Aquilina J. Prospective observational study to determine the accuracy of first-trimester serum biomarkers and uterine artery Dopplers in combination with maternal characteristics and arteriography for the prediction of women at risk of preeclampsia and other adverse. J Matern Neonatal Med. 2018;31(21):2789–2806.
   PubMed Web of Science ®Google Scholar
• Parlakgumus HA, Aytac PC, Kalaycı H, et al. First trimester maternal lipid levels and serum markers of small- and large-for-gestational age infants. J Matern Neonatal Med. 2014;27(1):48–51.
   PubMed Web of Science ®Google Scholar
• Wells G, Bleicher K, Han X, et al. Maternal diabetes, large-for-gestational-age births, and first trimester pregnancy-associated plasma protein-A. J Clin Endocrinol. Metab. 2015;100(6):2372–2379.
   PubMed Web of Science ®Google Scholar
• Goetzinger KR, Cahill AG, Macones GA, et al. Association of first-trimester low PAPP-A levels with preterm birth. Prenat Diagn. 2010;30: 313.
   Web of Science ®Google Scholar
• Pihl K, Sørensen TL, Nørgaard-Pedersen B, et al. First-trimester combined screening for Down syndrome: prediction of low birth weight, small for gestational age and pre-term delivery in a cohort of non-selected women. Prenat Diagn. 2008;28(3):247–253.
   PubMed Web of Science ®Google Scholar
• Jelliffe-Pawlowski LL, Shaw GM, Currier RJ, et al. Association of early-preterm birth with abnormal levels of routinely collected first- and second-trimester biomarkers. Am J Obstet Gynecol. 2013;208(6):492.e1–492.e11.
   PubMed Web of Science ®Google Scholar